Gene therapy randomised clinical trials in Europe – a review paper of methodology and design

by Krassimira Ilieva, Borislav Borissov, Mondher Toumi
Published 2020-01-01

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration

by Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi
Published 2018-01-01

Patient-reported outcome claims in European and United States orphan drug approvals

by Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi
Published 2018-01-01

Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*

by Borislav Borissov, Michael Urbich, Boryana Georgieva, Svetoslav Tsenov, Guillermo Villa
Published 2017-01-01

Why “American Patients First” is likely to raise drug prices outside of the United States

by Monique Dabbous, Cyprien Milea, Steven Simoens, Clement François, Claude Dussart, Lylia Chachoua, Borislav Borissov, Mondher Toumi
Published 2019-01-01